Literature DB >> 24682253

Effect of the human SOD1-G93A gene on the Nrf2/ARE signaling pathway in NSC-34 cells.

Fumin Wang1, Yucheng Lu2, Faying Qi3, Quanping Su2, Long Wang2, Cuiping You2, Fengyuan Che3, Jixu Yu3.   

Abstract

Dominant mutations in superoxide dismutase 1 (SOD1) are a frequent cause of the lethal neurodegenerative disease amyotrophic lateral sclerosis (ALS). The nuclear factor erythroid 2‑related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway is the major cellular defense mechanism against oxidative stress, however, its role in ALS remains to be fully elucidated. Therefore, the present study aimed to investigate whether the human SOD1-G93A gene affected the Nrf2/ARE signaling pathway in an ALS cell model. The soma became round and the number of neurites decreased in the NSC-34 cells transfected with the hSOD1-G93A gene, and the neurites were shorter and oxidative stress was increased compared with the normal NSC-34 cells. Furthermore, the mRNA and protein expression of Nrf2, heme oxygenase-1 and NAD(P)H: quinone oxidoreductase 1 was significantly decreased in the NSC-34 cells transfected with the human SOD1-G93A gene. The present study indicated that human SOD1-G93A damaged the Nrf2/ARE signaling pathway in the ALS cell model and reduced the ability of cells to protect against oxidative injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682253     DOI: 10.3892/mmr.2014.2087

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

Review 1.  Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

Authors:  Jeffrey R Liddell
Journal:  Antioxidants (Basel)       Date:  2017-08-18

Review 2.  Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy.

Authors:  Silvia Bono; Marco Feligioni; Massimo Corbo
Journal:  Mol Neurodegener       Date:  2021-10-18       Impact factor: 14.195

3.  ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling.

Authors:  Alice Goode; Sarah Rea; Melanie Sultana; Barry Shaw; Mark S Searle; Robert Layfield
Journal:  Mol Cell Neurosci       Date:  2016-08-20       Impact factor: 4.314

4.  Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy.

Authors:  Isabel Lastres-Becker; Gracia Porras; Marina Arribas-Blázquez; Inés Maestro; Daniel Borrego-Hernández; Patricia Boya; Sebastián Cerdán; Alberto García-Redondo; Ana Martínez; Ángeles Martin-Requero
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

Review 5.  The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.

Authors:  Stephanie M Boas; Kathlene L Joyce; Rita M Cowell
Journal:  Antioxidants (Basel)       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.